Gore Enhances Structural Heart Portfolio with Pipeline Deal

W. L. Gore & Associates is piping some money into a company that has been stealthily developing an entirely catheter-based repair procedure for patients with mitral valve disease. Flagstaff, AZ-based Gore has acquired Santa Rosa, CA-based Pipeline Medical Technologies for an undisclosed sum. Pipeline is developing a device designed to replicate the outcomes of a highly effective surgical procedure via a catheter, avoiding the trauma and many of the risks associated with open heart surgery. "Pipeline's cutting-edge repair procedure, for patients with mitral valve disease, has the potential to expand Gore's growing portfolio of treatments for structural heart disease, and it echoes our commitment to innovation across cardiac therapies," said David Abeyta, leader of Gore's medical products division. Gore said it intends to keep the acquired company as a wholly owned subsidiary that will retain the Pipeline name and operate independently of Gore. “We see an array of synergies working with Gore. The company is well recognized for its advanced material capabilities. Its long history of designing solutions for DMR [degenerative mitral regurgitation] treatment challenges already includes the Gore-Tex Suture for Chordae Tendineae used in surgical chordal repairs and we are excited to collaborate on future innovations in transcatheter mitral chordal repair,” said Pipeline founder Steven Bolling, MD, a mitral valve surgeon....
Source: MDDI - Category: Medical Devices Authors: Tags: Business Cardiovascular Source Type: news